Novo-Holdings-As

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
31
Total Value
1314623581
Accession Number
0000950123-25-005753
Form Type
13F-HR
Manager Name
Novo-Holdings-As
Data Enrichment
97% identified
30 identified1 unidentified

Holdings

31 positions • $1.3B total value
Manager:
Search and click to pin securities to the top
Page 2 of 2
Ceribell, Inc.
Shares:880.0K
Value:$16.9M
% of Portfolio:1.3% ($16.9M/$1.3B)
Verve Therapeutics, Inc.
Shares:3.0M
Value:$13.7M
% of Portfolio:1.0% ($13.7M/$1.3B)
ROCKET PHARMACEUTICALS, INC.
Shares:1.1M
Value:$7.3M
% of Portfolio:0.6% ($7.3M/$1.3B)
4D Molecular Therapeutics, Inc.
Shares:1.9M
Value:$6.3M
% of Portfolio:0.5% ($6.3M/$1.3B)
Lexeo Therapeutics, Inc.
Shares:1.1M
Value:$3.9M
% of Portfolio:0.3% ($3.9M/$1.3B)
LanzaTech Global, Inc.
Shares:15.8M
Value:$3.8M
% of Portfolio:0.3% ($3.8M/$1.3B)
IO Biotech, Inc.
Shares:3.4M
Value:$3.7M
% of Portfolio:0.3% ($3.7M/$1.3B)
Kyverna Therapeutics, Inc.
Shares:1.9M
Value:$3.6M
% of Portfolio:0.3% ($3.6M/$1.3B)
AbCellera Biologics Inc.
Shares:1.1M
Value:$2.5M
% of Portfolio:0.2% ($2.5M/$1.3B)
Marqeta, Inc.
Shares:441.6K
Value:$1.8M
% of Portfolio:0.1% ($1.8M/$1.3B)
36322Q206
Shares:99.9K
Value:$309.7K
% of Portfolio:0.0% ($309.7K/$1.3B)